Stock listing

Frankfurt:I7G Ipsen SA Aktie

German listing (Frankfurt) of Ipsen SA · home listing Euronext:IPN

Follow Ipsen SA into a list and get an email when it puts out news.

Share price · FWB:I7G

€159.50 EUR -3.60 (-2.2%)

Close on Nov 20, 2026

Past year +21.9% · daily closes, Nov 20, 2025 – Nov 6, 2026, adjusted for splits
Day range
€159.50 – €159.50 EURNov 20, 2026
Market cap
€13.15B EURAt the close on Nov 20, 2026 · price × 82.42M shares outstanding
52-week range
€115.66 – €173.39 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€7,725 EURMedian day 0 shares · 37 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026
Ipsen SA logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Euronext:IPN · Home€161.60 EUR-1.40 (-0.9%)95,521€163.70€164.30€161.60€163.00Close on Nov 20, 2026
OTC:IPSEY$45.10 USD+0.85 (+1.9%)100$45.10$45.10$45.10$44.25Close on Nov 20, 2026
Frankfurt:I7G€159.50 EUR-3.60 (-2.2%)—€159.50€159.50€159.50€163.10Close on Nov 20, 2026
Munich:I7G€159.60 EUR-4.50 (-2.7%)—€160.10€160.10€159.60€164.10Close on Nov 20, 2026
Frankfurt:I7G0€39.80 EUR-1.00 (-2.5%)—€39.80€39.80€39.80€40.80Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:I7G · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€155.80+1.136+0.7%€155.80€155.80€155.800
€154.66+2.841+1.9%€154.66€154.66€154.660
€151.82-1.586-1.0%€151.82€151.82€151.82166
€153.41-3.089-2.0%€153.41€153.41€153.410
€156.50+2.973+1.9%€156.50€156.50€156.500
€153.52+0.833+0.5%€153.52€153.52€153.52104
€152.69+1.775+1.2%€152.69€152.69€152.69204
€150.92+0.953+0.6%€150.92€150.92€150.9210
€149.96-0.662-0.4%€149.96€149.96€149.960
€150.62-0.963-0.6%€150.62€150.62€150.62340
€151.59+2.147+1.4%€151.59€151.59€151.59210
€149.44-1.219-0.8%€149.44€149.44€149.440
€150.66+1.134+0.8%€150.66€150.66€150.660
€149.53+1.075+0.7%€149.53€149.53€149.530
€148.45+2.051+1.4%€148.45€148.45€148.450
€146.40+0.94+0.6%€146.40€146.40€146.400
€145.46+3.589+2.5%€146.47€147.14€145.4640
€141.87-1.202-0.8%€141.87€141.87€141.870
€143.07+0.424+0.3%€143.07€143.07€143.070
€142.65+0.311+0.2%€142.65€142.65€142.650
€142.34-1.278-0.9%€142.34€142.34€142.3456
€143.62+3.705+2.6%€143.62€143.62€143.624
€139.91+0.859+0.6%€139.91€139.91€139.910
€139.05-1.07-0.8%€139.05€139.05€139.050
€140.12+1.458+1.1%€140.12€140.12€140.120
€138.66-1.179-0.8%€139.60€141.57€138.66660
€139.84-3.338-2.3%€139.84€139.84€139.840
€143.18+0.088+0.1%€143.18€143.18€143.180
€143.09+0.349+0.2%€143.09€143.09€143.090
€142.74-7.077-4.7%€142.74€142.74€142.740
€149.82+2.755+1.9%€149.82€149.82€149.822
€147.07-1.63-1.1%€147.07€147.07€147.070
€148.70+1.996+1.4%€148.70€148.70€148.700
€146.70-0.916-0.6%€146.70€146.70€146.700
€147.62-5.97-3.9%€152.85€153.53€147.00155
€153.59-4.054-2.6%€153.59€153.59€153.5970
€157.64-1.218-0.8%€157.64€157.64€157.640
€158.86-0.0690.0%€158.86€158.86€158.860
€158.93+2.67+1.7%€158.93€158.93€158.930
€156.26+1.097+0.7%€156.26€156.26€156.26382
€155.16-2.004-1.3%€155.16€155.16€155.1662
€157.16-0.767-0.5%€157.16€157.16€157.160
€157.93-3.134-1.9%€157.93€157.93€157.930
€161.06-2.226-1.4%€161.14€161.44€160.9614
€163.29-4.711-2.8%€163.29€163.29€163.290
€168.00-0.17-0.1%€168.00€168.00€168.00332
€168.17+0.926+0.6%€168.17€168.17€168.170
€167.25+5.469+3.4%€167.25€167.25€167.250
€161.78-0.0020.0%€161.78€161.78€161.780
€161.78-6.542-3.9%€161.78€161.78€161.780
€168.32+3.605+2.2%€168.32€168.32€168.3288
€164.72-1.309-0.8%€164.72€164.72€164.720
€166.02+1.601+1.0%€166.02€166.02€166.020
€164.42+2.81+1.7%€162.87€165.10€162.665
€161.61+0.218+0.1%€161.61€161.61€161.610
€161.40-3.374-2.0%€161.40€161.40€161.404
€164.77+2.053+1.3%€164.77€164.77€164.770
Ticker
Frankfurt:I7G
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
Frankfurt
Currency
EUR

What changed lately

Latest news

All Ipsen SA news

Ipsen SA on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
93 in the last 12 months · 138 in all · newest Nov 6, 2026 · oldest 2025
Calls
7 calls with a replay · 7 with a transcript · latest Jul 30, 2026
Decks
136 decks · latest Oct 22, 2026

Where Ipsen SA is listed

ListingExchangeCountryCurrency
Euronext:IPN · Home listingEuronextFranceEUR
LSIN:0MH6LSINUnited KingdomEUR
OTC:IPSEYOTCUnited StatesUSD
gettex:I7GgettexGermanyEUR
Tradegate:I7GTradegateGermanyEUR
LS Exchange:A0ESMGLS ExchangeGermanyEUR
Aquis:IPNPAquisUnited KingdomEUR
Lang & Schwarz:A0ESMGLang & SchwarzGermanyEUR
Aquis:IPNPAquisUnited KingdomEUR
Dusseldorf:I7GDusseldorfGermanyEUR
OTC:IPSEFOTCUnited StatesUSD
Frankfurt:I7G · This pageFrankfurtGermanyEUR
Hamburg:I7GHamburgGermanyEUR
Stuttgart:I7GStuttgartGermanyEUR
Munich:I7GMunichGermanyEUR
BIVA:IPNNBIVAMexicoMXN
BMV:IPNNBMVMexicoMXN
BX Swiss:IPNBX SwissSwitzerlandCHF
Dusseldorf:I7G0DusseldorfGermanyEUR
Frankfurt:I7G0FrankfurtGermanyEUR
Lang & Schwarz:A1J2CWLang & SchwarzGermanyEUR
LS Exchange:A1J2CWLS ExchangeGermanyEUR
Stuttgart:I7G0StuttgartGermanyEUR
Turquoise:IPNPTurquoiseUnited KingdomEUR
VIE:IPNViennaAustriaEUR

Valuation

P/E 30.0× against a median of 49.1×: 3rd lowest of 10 Pharmaceuticals companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
€12.31B EUR
P/E
30.0×
EV/sales
3.4×
EV/EBITDA
11.2×
Price/book
2.8×
Gross margin
70.6%
Operating margin
20.3%
Net margin
12.1%
Debt to equity
0.2×
Beta
No index for this market yet

Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Ipsen SA · EURONEXT:IPNUS$14.62BUS$13.51B30.0×3.4×11.2×2.8×12.1%0.2×n/a
Innovent Biologics, Inc. · HKEX:1801US$17.82BUS$15.17B146×7.8×75.7×5.7×6.2%0.1×n/a
Yunnan Baiyao Group Co. Ltd. Class A · SZSE:000538US$15.10BUS$13.13B19.4×2.0×n/a2.5×12.2%0.0×n/a
Jazz Pharmaceuticals plc · NASDAQ:JAZZUS$14.95BUS$18.48B72.6×3.9×n/a3.6×4.4%1.3×0.64
Laurus Labs Ltd. · NSE:LAURUSLABSUS$13.38BUS$13.66B92.5×16.2×53.2×20.5×17.1%0.4×n/a
Zydus Lifesciences Limited · NSE:ZYDUSLIFEUS$12.92BUS$13.86B28.6×4.2×17.9×4.3×13.8%0.5×n/a
Elanco Animal Health Incorporated · NYSE:ELANUS$12.87BUS$15.85Bn/a3.1×13.1×1.9×−2.9%0.5×1.20
Dr. Reddy's Laboratories Ltd. · NSE:DRREDDYUS$12.50BUS$12.46B41.4×3.5×22.6×3.0×8.5%0.2×n/a
Cipla Ltd · NSE:CIPLAUS$12.34BUS$11.27B39.5×3.7×21.6×3.2×10.4%0.0×n/a
Mankind Pharma Ltd. · NSE:MANKINDUS$11.88BUS$12.18B49.1×7.3×27.7×6.3×14.6%0.3×n/a
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A · SSE:600436US$11.64BUS$11.32B58.9×9.5×n/a5.5×16.7%0.0×n/a
Median of the othersUS$12.89BUS$13.40B49.1×4.1×22.6×3.9×11.3%0.3×0.92

Forecasts

Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.

Price target
162.23 EUR · Analysts' mean
EPS, year to Dec 2026
16.12 · 8 analysts
Revenue, year to Dec 2026
4.62B · 10 analysts

Team and board

Officers

OfficerRole
Michelle C. WernerEVP, President of North America
Pierrick LefrancExecutive Vice President
Régis MulotEVP, Chief Human Resources Officer

Board

DirectorRole
Catherine BradleyIndependent Director
Mariette FinetDirector

Events

Next results
Feb 11, 2027 (expected)

Calls

CallWhenStatus
Ipsen (Euronext:IPN) Q2 2026 Earnings CallThu, Jul 30, 2026 · 8:00 AM ETReplay
Ipsen (Euronext:IPN) Q1 2026 Earnings CallThu, Apr 23, 2026 · 8:00 AM ETReplay
Ipsen (Euronext:IPN) Q4 2025 Earnings CallThu, Feb 12, 2026 · 8:00 AM ETReplay
Ipsen (Euronext:IPN) Q3 2025 Earnings CallFri, Oct 24, 2025 · 8:00 AM ETReplay
Ipsen (Euronext:IPN) Q2 2025 Earnings CallThu, Jul 31, 2025 · 4:30 PM ETReplay
Ipsen (Euronext:IPN) Q1 2025 Earnings CallWed, Apr 16, 2025 · 8:00 AM ETReplay
Ipsen (Euronext:IPN) Q4 2024 Earnings CallThu, Feb 13, 2025 · 7:00 AM ETReplay

Results days

QuarterResultsShare move
Quarter to Mar 31, 2026Apr 23, 2026+1.8%
Q4 2025Feb 12, 2026 · After close+4.8%
Q2 2025Jul 31, 2025 · After close−0.5%
Q4 2024Feb 13, 2025−6.5%
Q2 2024Jul 25, 2024−7.0%
Q4 2023Feb 8, 2024+0.7%
Q2 2023Jul 27, 2023 · After close+1.8%
Q4 2022Feb 9, 2023 · Before open+7.1%
Q2 2022Jul 28, 2022 · Before open+16.2%
Q4 2021Feb 11, 2022 · Before open+6.4%
All 12 quarters
QuarterResultsShare move
Q2 2021Jul 29, 2021+4.7%
Q4 2020Feb 11, 2021−1.6%

Open Events

Decks

DeckKindSlidesDate
Q3 2026 Earnings PresentationEarnings20 slidesOct 22, 2026
H1 2026 Earnings PresentationEarnings38 slidesJul 30, 2026
Q1 2026 Earnings PresentationEarnings21 slidesApr 23, 2026
FY 2025 Earnings PresentationEarnings36 slidesFeb 12, 2026
J.P. Morgan Healthcare Conference 2026Conference27 slidesJanuary 2026
Q3 2025 Earnings PresentationEarnings22 slidesOct 22, 2025
H1 2025 Earnings PresentationEarnings33 slidesJul 31, 2025
Q1 2025 Earnings PresentationEarnings19 slidesApr 16, 2025
Fact Sheet (April 2025)Fact sheet1 slideApril 2025
FY2024 Earnings PresentationEarnings35 slidesFeb 13, 2025
Show 50 decks
DeckKindSlidesDate
J.P. Morgan Healthcare Conference 2025Conference30 slidesJanuary 2025
Investor Presentation (November 2024)Investor deck21 slidesNovember 2024
YTD 2024 Earnings PresentationEarnings25 slidesOct 23, 2024
H1 2024 Earnings PresentationEarnings37 slidesJul 25, 2024
Investor Presentation (June 2024)Investor deck34 slidesJune 2024
Shareholder Meeting (May 2024)Shareholder meeting71 slidesMay 28, 2024
Q1 2024 Earnings PresentationEarnings23 slidesApr 24, 2024
FY2023 Earnings PresentationEarnings33 slidesFeb 8, 2024
Investor Presentation (February 2024)Investor deck46 slidesFebruary 2024
Investor Day (December 2023)Investor day88 slidesDec 7, 2023
Technical Presentation (November 2023)Technical20 slidesNovember 2023
Jefferies London Healthcare Conference 2023Conference23 slidesNovember 2023
YTD 2023 Earnings PresentationEarnings23 slidesOct 26, 2023
AASLD 2023 Investor Science Conference CallConference28 slidesOctober 2023
Investor Presentation (September 2023)Investor deck28 slidesSeptember 2023
H1 2023 Earnings PresentationEarnings34 slidesJul 27, 2023
2023 Deutsche Bank Depositary Receipts Virtual Investor ConferenceConference32 slidesMay 2023
Oddo BHF Forum 2023Conference21 slidesMay 2023
Q1 2023 Earnings PresentationEarnings23 slidesApr 27, 2023
FY2022 Earnings PresentationEarnings34 slidesFeb 9, 2023
FY2022 Earnings PresentationEarnings28 slides2023
Non-Deal Roadshow (November 2022)Roadshow24 slidesNovember 2022
YTD 2022 Earnings PresentationEarnings22 slidesOct 27, 2022
Non-Deal Roadshow (September 2022)Roadshow27 slidesSep 23, 2022
H1 2022 Earnings PresentationEarnings33 slidesJuly 2022
Q1 2022 Earnings PresentationEarnings21 slidesApr 27, 2022
Non-Deal Roadshow (March 2022)Roadshow33 slidesMarch 2022
FY2021 Earnings PresentationEarnings39 slidesFeb 11, 2022
JP Morgan Healthcare Conference 2022Conference20 slidesJanuary 2022
Investor Presentation (December 2021)Investor deck20 slidesDecember 2021
Q3 2021 Earnings PresentationEarnings22 slidesOct 21, 2021
Investor Presentation (August 2021)Investor deck25 slidesAugust 2021
H1 2021 Earnings PresentationEarnings32 slidesJul 29, 2021
H1 2021 Earnings PresentationEarnings32 slidesJul 29, 2021
Investor Presentation (June 2021)Investor deck40 slidesJune 2021
Q1 2021 Earnings PresentationEarnings16 slidesApr 22, 2021
FY2020 Earnings PresentationEarnings26 slidesFeb 11, 2021
FY2020 Earnings PresentationEarnings26 slidesFeb 11, 2021
Investor Day (December 2020)Investor day77 slidesDec 1, 2020
Q3 2020 Earnings PresentationEarnings19 slidesOct 22, 2020

This page holds 50 of 136 decks. Open Decks

Open Decks

Financials

Annual, in EUR

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue3.68B3.57B3.31B3.16B3.00B2.69B2.69B2.35B2.01B1.67B
Cost of revenue1.08B618.7M571.2M527.7M438.6M490.6M488.0M454.2M385.6M351.1M
Gross profit2.59B2.96B2.74B2.63B2.31B2.20B2.20B1.89B1.63B1.32B
Research and development754.0M686.6M619.3M445.3M424.4M405.6M388.8M302.1M265.8M231.3M
Selling, general and administrative219.0M216.3M217.8M205.8M188.2M187.8M181.4M165.7M140.8M125.6M
Operating income746.3M496.7M816.0M729.9M824.7M524.8M701.8M555.3M400.4M348.2M
Depreciation and amortization356.3M705.9M296.6M336.5M237.0M234.7M161.2M142.6M97.9M39.1M
EBITDA1.10B1.20B1.11B1.07B1.06B759.5M863.0M697.9M498.3M387.3M
Interest expense36.1M23.8M19.4M23.8M23.7M27.1M30.0M8.40M9.20M4.60M
Income before tax578.2M432.2M756.1M704.4M789.5M531.1M-34.8M495.2M372.0M299.9M
Income tax133.6M74.9M136.2M112.3M158.3M-17.8M19.6M108.1M101.4M73.5M
Net income444.5M345.9M644.4M648.6M646.6M548.0M-54.9M389.5M272.3M225.9M
Earnings per share, basic5.324.187.797.877.826,610.00-0.664.683.282.73
Earnings per share, diluted4.157.737.817.766,570.00

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents1.53B678.1M528.4M1.17B814.7M642.5M353.3M344.5M228.0M425.5M
Short-term investments1.00M1.10M10.6M31.0M42.4M26.8M59.3M600.0K155.1M6.60M
Receivables932.1M697.2M631.3M632.5M564.3M476.2M588.8M463.0M437.2M363.5M
Inventory256.6M285.5M289.5M284.1M219.4M213.9M214.0M198.5M167.4M113.3M
Current assets2.82B2.02B1.90B2.40B1.95B1.58B1.35B1.19B1.02B1.05B
Property, plant and equipment574.6M581.4M647.5M646.6M679.3M474.3M418.6M379.0M
Goodwill633.8M699.5M663.9M579.9M623.2M592.8M632.6M395.6M389.0M357.2M
Total assets6.94B6.44B6.32B5.61B4.99B4.31B4.31B3.38B3.07B2.42B
Accounts payable854.2M854.8M771.4M647.1M594.7M495.2M508.5M379.8M319.1M241.5M
Current liabilities1.44B1.51B1.63B1.34B1.23B1.21B1.45B959.2M941.7M561.3M
Long-term debt748.2M287.5M269.7M667.0M772.2M542.7M568.2M297.9M297.5M297.1M
Total debt867.1M426.8M462.9M771.6M895.9M1.17B1.47B587.3M590.2M340.5M
Total liabilities2.60B2.26B2.50B2.27B2.25B2.18B2.55B1.53B1.54B1.06B
Shareholders' equity4.34B4.18B3.83B3.34B2.74B2.13B1.75B1.84B1.53B1.36B
Shares outstanding83.6M83.4M83.4M83.1M83.4M83.4M83.5M83.2M83.0M82.6M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations1.14B915.5M865.9M971.4M893.3M771.3M627.7M570.9M422.9M317.8M
Capital spending-105.3M-782.5M-116.2M-252.9M-96.0M-81.4M-280.6M-105.9M-84.5M-81.1M
Free cash flow1.03B133.0M749.7M718.5M797.3M689.9M347.1M465.0M338.4M236.7M
Cash from investing-615.2M-676.6M-1.08B-458.6M-332.0M-163.7M-1.16B-274.3M-777.2M-357.1M
Cash from financing298.4M-100.0M-452.4M-164.2M-421.8M-307.5M550.0M-202.2M135.2M252.0M
Dividends paid-116.2M-99.6M-99.6M-100.2M-83.1M-83.5M-83.2M-83.0M-70.2M-70.0M
Share buybacks-67.7M-36.5M-39.5M-11.3M-36.7M-36.4M-16.8M-10.3M-17.5M-17.7M
Change in cash847.4M138.9M-664.7M348.6M139.5M300.1M28.1M101.6M-213.2M208.5M

Open Financials

Filings

FilingDateTypeFiled with
Ipsen - October 2026 - Monthly information relative to the total number of voting rights and shares composing the share capitalNov 6, 2026Other filingsEuronext
IQIRVO® late-breaking data raises ambitions in PBC with more than 85% of patients on treatment achieving ALP normalizationNov 5, 2026Other filingsEuronext
Ipsen delivers outstanding sales growth in the first nine months of 2026 and further upgrades its full-year guidanceOct 22, 2026GuidanceEuronext
Ipsen - September 2026 - Monthly information relative to the total number of voting rights and shares composing the share capitalOct 7, 2026Other filingsEuronext
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 39 - 2026Sep 28, 2026Other filingsEuronext
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 38 - 2026Sep 21, 2026Other filingsEuronext
Ipsen nomme Mariette Finet administratrice au sein de son Conseil d’administrationSep 17, 2026Other filingsEuronext
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 37 - 2026Sep 13, 2026Other filingsEuronext
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 36 - 2025Sep 6, 2026Other filingsEuronext
Ipsen - Août 2026 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital socialSep 2, 2026Other filingsEuronext
All 11 filings
FilingDateTypeFiled with
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 35 - 2026Aug 30, 2026Other filingsEuronext

Open Filings

Cap table

Built by 6ix from Ipsen SA’s releases

Common shares
82,417,038
Fully diluted
82,417,038

Fully diluted

LineShares
Common shares82,417,038

Share count over time

CountShares
Nov 22, 202682,417,038

Open Cap table

Shareholders

Institutions

HolderSharesValueChange vs Jun 30Filed
Ativo Capital Management LLC38,700US$1.62M−53Oct 27, 2026

Funds

HolderSharesValueChangeAs of
Vanguard Total International Stock Index Fund514KUS$99.4M+4,624Jul 31, 2026
Vanguard Developed Markets Index Fund337KUS$65M−1,758Jun 30, 2026
iShares Core MSCI EAFE ETF269KUS$52M+3,104Jul 31, 2026
Disciplined Value International Fund249KUS$48MNo changeJul 31, 2026
Fidelity SAI International Low Volatility Index Fund192KUS$36.9M+10,677Jul 31, 2026
International Core Equity 2 Portfolio155KUS$30MNo changeJul 31, 2026
Fidelity International Index Fund142KUS$25.9M+4,394May 31, 2026
Victory Trivalent International Small-Cap Fund133KUS$25.6MNo changeJun 30, 2026
iShares MSCI EAFE ETF130KUS$25.1M−1,901Jul 31, 2026
The Continental Small Company Series98,626US$19.1MNo changeJul 31, 2026
Show 50 holders
HolderSharesValueChangeAs of
iShares MSCI EAFE Value ETF89,119US$17.2M−9,002Jul 31, 2026
Avantis International Equity ETF86,808US$15.9M+14,230May 31, 2026
Vanguard Ftse All-World Ex-Us Index Fund82,727US$16M+2,255Jul 31, 2026
Vanguard European Stock Index Fund82,701US$16M−2,134Jul 31, 2026
Goldman Sachs ActiveBeta(R) International Equity ETF78,749US$14.4M+532May 31, 2026
Schwab International Equity ETF78,223US$14.3M+2,028May 31, 2026
Lazard International Dynamic Equity ETF77,350US$14.9MNewJun 30, 2026
Tax-Managed International Equity Fund70,805US$13.7MNo changeJul 31, 2026
BlackRock Advantage International Fund68,291US$12.5M−22,981May 29, 2026
Schwab International Core Equity Fund67,349US$13MNo changeJul 31, 2026
Fidelity Series Global ex U.S. Index Fund66,814US$12.9M−4,975Jul 31, 2026
AQR Long-Short Equity Fund64,771US$12.5M+22,413Jun 30, 2026
Nuveen International Equity Index Fund53,805US$10.4M−5,910Jul 31, 2026
Dimensional International Core Equity 2 ETF49,282US$9.48M+728Jul 31, 2026
iShares Core MSCI Total International Stock ETF48,514US$9.37M+576Jul 31, 2026
Six Circles International Unconstrained Equity Fund47,671US$9.19M−5,652Jun 30, 2026
iShares MSCI Eurozone ETF45,833US$8.37M−3,511May 31, 2026
iShares Core MSCI International Developed Markets ETF44,509US$8.6M−56Jul 31, 2026
Schwab Health Care Fund44,466US$8.59M+9,271Jul 31, 2026
Hartford Schroders International Multi-Cap Value Fund43,800US$8.46MNo changeJul 31, 2026
GMO International Equity Fund41,212US$7.53M+14,450May 31, 2026
State Street(R) SPDR(R) Portfolio Developed World ex-US ETF40,908US$7.89M−40Jun 30, 2026
iShares Genomics Immunology and Healthcare ETF37,928US$7.33M−4,882Jul 31, 2026
International Equity Index Fund34,036US$6.56M+15,104Jun 30, 2026
Dimensional International Core Equity Market ETF33,639US$6.47M+2,602Jul 31, 2026
Dimensional International Small Cap ETF33,105US$6.37M−5,501Jul 31, 2026
Disciplined Value International Trust29,667US$5.72M+15,665Jun 30, 2026
Catholic Responsible Investments International Equity Fund28,951US$5.58MNo changeJul 31, 2026
Vanguard Total World Stock Index Fund27,670US$5.35MNo changeJul 31, 2026
Six Circles Managed Equity Portfolio International Unconstrained Fund26,984US$5.2M−197Jun 30, 2026
Fidelity Enhanced International ETF26,642US$5.14M+22,085Jun 30, 2026
Dimensional World ex. U.S. Core Equity 2 ETF26,329US$5.06MNo changeJul 31, 2026
Victory International Fund26,128US$4.77M+14,298May 31, 2026
Avantis International Large Cap Value ETF24,808US$4.53M+16,024May 31, 2026
Domini Impact International Equity Fund23,300US$4.5MNo changeJul 31, 2026
Schwab International Index Fund22,285US$4.31M−2,310Jul 31, 2026
SIT International Equity Fund21,908US$4.22M−4,137Jun 30, 2026
Schwab Fundamental International Small Equity ETF21,577US$3.94M−1,632May 31, 2026
iShares MSCI EAFE International Index Fund21,238US$4.09M−2,179Jun 30, 2026
iShares Core MSCI Europe ETF20,899US$4.04M+35Jul 31, 2026

This page holds 50 of 300 holders. Open Shareholders

Big stakes

HolderStakeSharesDate
BlackRock Inc.5.04%4.22MOct 23, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Catherine BradleyIndependent Director · Since at least Jul 29, 2026
Mariette FinetDirector · Since at least Sep 18, 2026
Michelle C. WernerEVP, President of North America · Since at least Mar 12, 2026
Pierrick LefrancExecutive Vice President · Since at least Jan 27, 2026
Régis MulotEVP, Chief Human Resources Officer · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Ipsen SA.